Initially, Pfizer manufactured Pyridium. They held the patent and controlled production for many years. This period saw consistent manufacturing processes focused on tablet production.
Post-Patent Production
Following patent expiration, generic manufacturers entered the market. Companies like Teva Pharmaceuticals and Mylan Pharmaceuticals began producing and distributing generic phenazopyridine, the active ingredient in Pyridium. This led to increased competition and variations in production methods and formulations, including different tablet sizes and coatings.
Current Production Trends
Current production primarily involves large-scale manufacturing processes optimized for cost-effectiveness. Many generic manufacturers utilize similar methods, focusing on consistent quality control to meet regulatory standards. There’s ongoing research into alternative formulations, but tablet form remains dominant.
